# Real-World Treatment Study of Koselugo (Selumetinib)

> **NCT06360406** · — · RECRUITING · sponsor: **AstraZeneca** · enrollment: 200 (estimated)

## Conditions studied

- Neurofibromatosis 1
- Neurofibroma, Plexiform

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06360406
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-15
- **Primary completion:** 2031-09-30
- **Final completion:** 2031-09-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06360406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06360406, "Real-World Treatment Study of Koselugo (Selumetinib)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06360406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*